Ph reversible response mesoporous silicon oxide composite medicament-carrying system, preparation method thereof and application thereof
A technology of mesoporous silica and silicon oxide, which is applied in pharmaceutical formulations, medical preparations of non-active ingredients, gene therapy, etc., to achieve the effects of high-efficiency drug release, excellent magnetic targeting effect, and excellent biocompatibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1 3
[0054] The synthesis of embodiment 1 triaminomethylethane-3 hydrochloric acid compound (TAE 3HCl)
[0055] Sodium azide (7 g) and 60 ml of DMF were added into the flask, stirred, then tribromoneopentyl alcohol (3.3 g) was added, the reaction system was heated to 90 degrees, and stirred for 28 hours under the protection of nitrogen. After the reaction was finished, the obtained product was poured into 500 ml of water, and extracted with ether (38 ml*4), the ether extracts obtained were combined together, dried with magnesium sulfate, filtered, and the volume of the solution was concentrated to 50ml. Then dioxane (125 ml), triphenylphosphine (13.3 g) and ammonia water (aq, 30%, 50 ml) were added to the solution, and stirred at room temperature for 19 hours. The solution of the product after stirring for 19 hours was sucked off, and the obtained product was dispersed in chloroform (200 ml), then extracted with HCl (aq, 2.5M, 38ml*5), and the obtained extracts were combined toget...
Embodiment 2 3
[0056] Synthesis of embodiment 2 triazadamantane compound (TAA)
[0057] Triethylamine (1.65ml) was added dropwise to the product in 0.8 gram of embodiment 1 dissolved in 10ml of methanol, stirred, and added benzaldehyde (1.05ml), the mixture was stirred and heated to reflux, and the reaction stopped after 20 minutes. Cool and evaporate the solvent, add 10 ml of water to the obtained product, stir and filter, so as to obtain the target product (triazaadamantane) protected by benzaldehyde, which can be used for the next reaction. Product liquid phase NMR results: 1 H NMR (400MHz, CDCl 3 )δ7.21-7.89 (m, 15H, Ar), 5.62 (s, 1H, PhCH eq ), 5.42 (s, 2H, PhCH ax ), 3.53 (d, J=13.2Hz, 2H, -CH 2 N-), 3.22 (d, J=12.9Hz, 2H, -CH 2 N-), 3.07(s, 1H, OH), 2.93(s, 4H, -CH 2 N-, -CH 2 O-).
Embodiment 34
[0058] The synthesis of embodiment 34-carboxybenzaldehyde-dimethoxy acetal (CBA-DMA)
[0059] 4 grams of 4-carboxybenzaldehyde were dispersed in 80 milliliters of methanol solution, 8 grams of ammonium chloride solid was added, and the reaction was heated under reflux for 20 hours. The solvent was removed by a rotary evaporator, and the white target product was obtained by recrystallization from n-hexane.
PUM
Property | Measurement | Unit |
---|---|---|
pore size | aaaaa | aaaaa |
diameter | aaaaa | aaaaa |
pore size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com